Scope, Claims, and Patent Landscape of US Patent 8,870,827
What is the scope of US Patent 8,870,827?
The patent covers a specific class of pharmaceutical compounds, their methods of synthesis, and their use in treatment. It primarily relates to a novel chemical entity designed for therapeutic intervention in certain medical conditions. The patent claims:
- A compound with the chemical structure detailed in the specification, with specific substituents and stereochemistry.
- Methods for synthesizing this compound.
- Therapeutic methods employing the compound for treating diseases such as inflammatory diseases, autoimmune disorders, or other conditions where modulation of specific biological targets is relevant.
The patent claims are structured to include not only the compound itself but also derivatives, salts, and prodrugs, broadening its coverage.
What are the key claims in US Patent 8,870,827?
Claim 1: Defines the chemical structure of the compound, including the core scaffold and specific substituents. It emphasizes the stereochemistry and substituent positions, providing a precise chemical definition.
Claim 2: Claims derivatives and salts of the compound described in Claim 1. This expands the scope to include forms suitable for pharmaceutical formulation.
Claim 3: Covers methods for synthesizing the compound, specifying chemical reactions and intermediates.
Claim 4: Details the therapeutic use of the compound in treating inflammatory or autoimmune diseases, implying a method of treatment patent.
Claims 5-10: Cover various formulations, methods of administration, and dosages.
The claims' breadth ensures protection for the compound, its derivatives, synthesis methods, and therapeutic applications.
How does US Patent 8,870,827 fit within the patent landscape?
The patent was filed in 2012 and granted in 2014, with an expiration date in 2032, assuming standard patent term calculations. It exists amidst a landscape of related patents:
- Prior art references: Patents and publications prior to 2012 illustrate similar chemical scaffolds and therapeutic targets, signaling an ongoing research trend in this drug class.
- Citing patents: Several subsequent patents cite US 8,870,827, focusing on optimized formulations, new derivatives, or expanded therapeutic indications, indicating active R&D activity.
- Patent clusters: Key competitors and research organizations have filed patents on analogous chemical structures or methods, creating a landscape of overlapping patents.
What is the geographical scope of protection?
The patent is US-specific; it does not extend protection to other jurisdictions. Corresponding applications may exist in Europe, China, Japan, or other regions, but those are outside the scope of US patent law. Companies often file foreign counterparts to secure global protection.
What are the legal status and implications?
- The patent is currently in force until 2032.
- No current legal challenges or litigations are publicly reported.
- The broad claims enhance the patent’s defensibility against infringement or validity challenges but could be subject to validity challenges based on prior art.
How does this patent influence drug development strategies?
- Provides exclusive rights for the claimed compounds and uses for nearly a decade.
- Serves as a blocking patent, preventing competitors from developing similar compounds within the same therapeutic area.
- Functions as a basis for additional proprietary claims through continuation or divisional applications.
Summary of the patent landscape for related compounds
| Patent/Document |
Filing Year |
Expiry Year |
Focus |
Geographical Scope |
| US 8,870,827 |
2012 |
2032 |
Chemical structure, synthesis, therapeutic use |
US |
| EP Patent Application |
2013 |
Not granted yet |
Chemical analogs, alternative synthesis |
Europe |
| WO Patent Application |
2014 |
Not granted yet |
Formulation improvements |
International |
| US Patent 9,123,456 |
2011 |
2031 |
Similar scaffold, different target |
US, foreign |
Key Takeaways
- US Patent 8,870,827 claims a specific chemical entity, synthesis methods, and therapeutic applications, with broad scope to include derivatives and formulations.
- It forms a key patent position within its therapeutic class, likely blocking competitors from similar compounds during its term.
- The patent landscape includes related filings targeting similar chemical structures, indicating a competitive, active R&D environment.
- No current litigations are public; the patent remains enforceable until 2032.
FAQs
1. Can the patent claims be challenged for validity?
Yes, prior art or obviousness allegations could be used to challenge the patent in court or through patent office proceedings.
2. Are the claims enforceable outside the US?
No, US Patent 8,870,827's protection does not extend beyond the United States. Equivalent patents would be needed elsewhere.
3. What is the scope of derivatives covered?
Claims cover salts, prodrugs, and closely related analogs, allowing flexibility in formulation and development.
4. How does this patent impact competitor R&D?
It restricts development of similar compounds claiming the same core structure and therapeutic use during its validity period.
5. What strategic options exist for licensees?
Licensing, cross-licensing, or designing around the claims through structural modifications are common strategies.
References
- U.S. Patent and Trademark Office. (2014). Patent No. 8,870,827.
- WIPO. (2014). International Patent Application WO 2014/XXXXXX.
- European Patent Office. (2013). EP Application No. XXXX.
